Key result
Nadir hematocrit >30% during CPB is linked to ~46% lower AKI risk vs <25%.
Why the study?
Does maintaining a higher intraoperative nadir hematocrit reduce the risk of AKI and composite complications in children under 14 years old with cyanotic congenital heart disease undergoing cardiopulmonary bypass?
Population
3158 children under 14 years old with cyanotic congenital heart disease who underwent cardiopulmonary bypass…
Comparison
Intraoperative nadir hematocrit 25%-30% or >30% vs Intraoperative nadir hematocrit (Hct) <25%
Design
Cohort
Authors
Loading...
In children with cyanotic congenital heart disease undergoing cardiopulmonary bypass, maintaining an intraoperative nadir hematocrit above 25% is associated with a lower risk of acute kidney injury and composite complications.
Cohort (n=3,158)
No
Does maintaining a higher intraoperative nadir hematocrit reduce the risk of AKI and composite complications in children under 14 years old with cyanotic congenital heart disease undergoing cardiopulmonary bypass?
Odds Ratio: 0.54 (95% CI 0.4–0.74)
p-value: p=<0.001
In children with cyanotic congenital heart disease undergoing cardiopulmonary bypass, maintaining an intraoperative nadir hematocrit above 25% is associated with a lower risk of acute kidney injury and composite complications.
Liu et al. (2025) conducted a cohort in Cyanotic congenital heart disease (n=3,158). Intraoperative nadir hematocrit >30% vs. Intraoperative nadir hematocrit <25% was evaluated on Acute kidney injury (AKI) (OR 0.54, 95% CI 0.40-0.74, p=<0.001). Intraoperative nadir hematocrit >30% during cardiopulmonary bypass was associated with a reduced risk of acute kidney injury compared to <25% (OR 0.54; 95% CI 0.40-0.74; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: